Medical Prognosis Institute AS (MPI)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Medical Prognosis Institute AS (MPI) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010882
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Medical Prognosis Institute A/S (MPI) is a precision medicine provider that offers cancer treatment solutions. The company offers DRP platforms that provide tools for rationalized drug development and personalized medicine. It offers lead compound selection, drug rescue repositioning repurposing, patient selection, drug combinations, pathway elucidation, new indications, indication selection and companion diagnostic programs. MPI also offers drug specific interface to the human genome and predict drug response in individual patients. The company has partnerships with various cancer drug developing companies. It operates in Denmark and the US. MPI is headquartered in Horsholm, Denmark.

Medical Prognosis Institute AS (MPI) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Medical Prognosis Institute A/S, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Medical Prognosis Institute A/S, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Medical Prognosis Institute A/S, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Medical Prognosis Institute A/S, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Medical Prognosis Institute A/S, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Medical Prognosis Institute A/S, Medical Equipment, Deal Details 10
Oncology Venture Enters into Licensing Agreement with Medical Prognosis Institute 10
Equity Offering 11
Medical Prognosis Institute Raises USD1.2 Million in Rights Offering of Shares 11
Medical Prognosis Raises USD1.7 Million in Rights Issue of Shares 12
Medical Prognosis Institute A/S – Key Competitors 13
Medical Prognosis Institute A/S – Key Employees 14
Medical Prognosis Institute A/S – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Financial Announcements 16
Aug 31, 2017: MPI publishes Half-year Report for the first half of 2017 16
Mar 31, 2017: MPI publishes Annual Report for 2016 18
Product News 19
Jan 28, 2016: MPI Is Issued Patent In Australia 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Medical Prognosis Institute A/S, Medical Equipment, Key Facts, 2016 2
Medical Prognosis Institute A/S, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Medical Prognosis Institute A/S, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Medical Prognosis Institute A/S, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Medical Prognosis Institute A/S, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Medical Prognosis Institute A/S, Deals By Market, 2011 to YTD 2017 8
Medical Prognosis Institute A/S, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Oncology Venture Enters into Licensing Agreement with Medical Prognosis Institute 10
Medical Prognosis Institute Raises USD1.2 Million in Rights Offering of Shares 11
Medical Prognosis Raises USD1.7 Million in Rights Issue of Shares 12
Medical Prognosis Institute A/S, Key Competitors 13
Medical Prognosis Institute A/S, Key Employees 14
Medical Prognosis Institute A/S, Subsidiaries 15

★海外企業調査レポート[Medical Prognosis Institute AS (MPI)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Gland Pharma Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Gland Pharma Ltd (Gland Pharma) is a healthcare products provider that develops and manufactures active pharmaceutical ingredients. The company’s products include injectables, pre filled syringes, vials, ampoules, infusions, ophthalmic solutions, lyophilized vials, dry powders, lyophilized p …
  • Sunwin Stevia International Inc (SUWN):企業の財務・戦略的SWOT分析
    Sunwin Stevia International Inc (SUWN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Lietuvos energijos gamyba, AB (LNR1L):企業の財務・戦略的SWOT分析
    Lietuvos energijos gamyba, AB (LNR1L) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Systemax Inc.:企業の戦略・SWOT・財務情報
    Systemax Inc. - Strategy, SWOT and Corporate Finance Report Summary Systemax Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Indigo Biosciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Indigo Biosciences Inc (Indigo) is a provider of preclinical contract research services for pharmaceutical research and development, biotechnology sectors. The company’s products include assay kit platforms and formats, nuclear receptor, signaling pathway, and cell viability assay products, …
  • Thien Viet Securities Joint Stock Company:企業の戦略的SWOT分析
    Thien Viet Securities Joint Stock Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Oric Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Oric Pharmaceuticals Inc (Oric Pharmaceuticals) is an independent oncology company that focuses to discover and develop drugs for overcoming resistance in cancer. Its lead drug candidate ORIC-101, which is in phase 1 clinical trial, is a small molecule inhibitor of the glucocorticoid recepto …
  • Daybreak Oil and Gas Inc (DBRM):石油・ガス:M&Aディール及び事業提携情報
    Summary Daybreak Oil and Gas Inc (Daybreak) is an oil and gas company that explores and develops oil and natural gas assets. The company’s projects include East Slopes project and Michigan Basin project. Its East Slopes project is located in south-eastern art of the San Joaquin Basin, California. Da …
  • Fagron NV (FAGR):企業の財務・戦略的SWOT分析
    Summary Fagron NV (Fagron), is a pharmaceutical company that provides compounding solutions. The company offers products such as raw materials, flammable products, extracts and tinctures; anesthetic, syrups, ointment bases, medispend, triturations, suspension media, phyto pharmaflore, capsicards sys …
  • Steward Health Care System LLC:企業の戦略的SWOT分析
    Steward Health Care System LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Pantheon Resources plc (PANR):企業の財務・戦略的SWOT分析
    Summary Pantheon Resources Plc (Pantheon Resources) is an oil and gas exploration and production company. It explores, develops and produces crude oil and natural gas resource properties. The company invests in oil and gas exploration and development. It operates hydrocarbon producing basins onshore …
  • Humana Inc (HUM)-製薬・医療分野:企業M&A・提携分析
    Summary Humana Inc (Humana) is a health and well-being company that offers health insurance and Medicare plans, insurance products, and health and wellness services to healthcare providers, employers, individuals, administrators, government, and the public sector. The company’s Medicare products and …
  • Salvatore Ferragamo SpA (SFER):企業の財務・戦略的SWOT分析
    Salvatore Ferragamo SpA (SFER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Analytica Limited (ALT):医療機器:M&Aディール及び事業提携情報
    Summary Analytica Limited (Analytica) is a specialty diagnostic and laboratory equipment company. It designs, develops and supplies Class I and II medical devices. The company provides women’s health systems and intravenous (IV) medication delivery systems. Its major products include PeriCoach e-hea …
  • Integracion Energetica Argentina SA:企業の戦略的SWOT分析
    Integracion Energetica Argentina SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • MicroTransponder Inc:医療機器:M&Aディール及び事業提携情報
    Summary MicroTransponder Inc (MicroTransponder) is a medical device company that develops paired vagus nerve stimulation systems. The company provides paired VNS system which is used in two clinical trials for treating tinnitus and upper limb mobility issues for stroke patients. It also develops SAI …
  • Bank of Communications Ltd (601328):企業の財務・戦略的SWOT分析
    Bank of Communications Ltd (601328) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Verallia Deutschland AG:企業の戦略・SWOT・財務情報
    Verallia Deutschland AG - Strategy, SWOT and Corporate Finance Report Summary Verallia Deutschland AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Trethera Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Trethera Corp (Trethera), formerly Triangle Therapeutics Inc is a clinical-stage biopharmaceutical company that discovers and develops novel therapies and treatment strategies in oncology. The corporation’s lead program combines TRE-515, a novel deoxycytidine kinase inhibitor with Triapine, …
  • China Digital Culture (Group) Ltd (8175):企業の財務・戦略的SWOT分析
    China Digital Culture (Group) Ltd (8175) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆